Trials / Completed
CompletedNCT03934697
Imaginal Exposure II Study: In-Vivo
In-Vivo Treatment for Imaginal Exposure Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- University of Louisville · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test if imaginal exposure therapy can decrease symptoms of eating disorders and anxiety.
Detailed description
An initial meeting consisting of a screening, questionnaires, and a brief psychoeducation on imaginal exposure therapy, followed by 8-10 sessions with a licensed psychologist (the PI) or a clinical psychology graduate student who is supervised and trained by the PI. In Session 1, patients will create a script with the therapist on an eating disorder fear. In sessions 2-10 the therapist and patient will then imagine this eating disorder related fear based on the script. Each session will be modified to focus on "hot spots" or the most feared aspect of the script. Sessions will be audiotaped and videotaped and participants will be asked to listen to the sessions nightly for homework. Sessions will be weekly or twice per week for 8-10 weeks after the initial screening session.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | imaginal exposure therapy | All participants will complete the same arm, which is ten sessions of imaginal exposure across a ten week time period. Each session is separated by 1 week. |
Timeline
- Start date
- 2017-05-01
- Primary completion
- 2020-12-13
- Completion
- 2022-10-01
- First posted
- 2019-05-02
- Last updated
- 2024-03-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03934697. Inclusion in this directory is not an endorsement.